FDA Approves Exact Sciences' Cologuard; CMS Issues Proposed National Coverage Determination | GenomeWeb

NEW YORK (GenomeWeb) – The US Food and Drug Administration on Monday approved Exact Sciences' Cologuard colorectal cancer screening test, while the Centers for Medicare and Medicaid Services issued a proposed national coverage determination for the test.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: role for epigenetic in neuronal excitability, and more.

The new Office of Research Integrity director is grappling with complaints from her staff, according to ScienceInsider.

Italian researchers link SNPs in the PDSS2 gene to coffee consumption in a new paper.

A gene-editing ban has been interpreted to include mitochondrial transfer, Technology Review reports.